InsidersTradesSigma
Follow the Insys Therapeutics, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 9 February 2016 (Levée d'options). Among the most active insiders: MEYER STEVEN J. Every trade is accessible without an account.
Analysts rate Insys Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Insys Therapeutics, Inc. es una empresa farmacéutica enfocada en el desarrollo de tratamientos, particularmente para el manejo del dolor. Cotiza en el NASDAQ bajo el símbolo INSY.